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Abstract
Background—Broad adoption of interventions that prove effective in randomized clinical trials 
or comparative effectiveness research may depend to a great extent on their costs and cost-
effectiveness (CE). Many studies of behavioral health interventions for oral health promotion and 
disease prevention lack robust economic assessments of costs and CE.
Objective—To describe methodologies employed to assess intervention costs, potential savings, 
net costs, CE, and the financial sustainability of behavioral health interventions to promote oral 
health.
Methods—We provide an overview of terminology and strategies for conducting economic 
evaluations of behavioral interventions to improve oral health based on the recommendations of 
the Panel of Cost-Effectiveness in Health and Medicine. To illustrate these approaches, we 
summarize methodologies and findings from a limited number of published studies. The strategies 
include methods for assessing intervention costs, potential savings, net costs, CE, and financial 
sustainability from various perspectives (e.g., health-care provider, health system, health payer, 
employer, society). Statistical methods for estimating short-term and long-term economic 
outcomes and for examining the sensitivity of economic outcomes to cost parameters are 
described.
Discussion—Through the use of established protocols for evaluating costs and savings, it is 
possible to assess and compare intervention costs, net costs, CE, and financial sustainability. The 
addition of economic outcomes to outcomes reflecting effectiveness, appropriateness, 
acceptability, and organizational sustainability strengthens evaluations of oral health interventions 
and increases the potential that those found to be successful in research settings will be 
disseminated more broadly.
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Introduction
In addition to understanding the effectiveness of interventions to prevent and control oral 
disease, health providers, payers, and policymakers need reliable information about 
intervention costs and cost-effectiveness (CE) if they are to make informed decisions about 
allocating resources. With health-care costs increasing rapidly, translation of interventions 
documented to be effective in research settings may be limited if reliable and accurate 
estimates of costs and CE are not available. Although the CE of community water 
fluoridation and dental sealants has been documented (1–9), and CE research on dental 
procedures in clinical settings is growing (10–15), research on the CE of interventions 
implemented to improve oral health knowledge, attitudes, and behaviors is limited. Because 
health behaviors and lifestyle influence oral health and long-term health, and have economic 
and social consequences, it is important to identify effective and cost-effective behavioral 
interventions to promote oral health and to reduce documented oral health disparities (16).
Economic analyses may vary with regard to types of costs measured, how costs are 
determined, methods employed to assess potential intervention savings, and documentation. 
This variability may reflect differences in resources allocated to cost analyses, or 
unfamiliarity with methods employed in conducting such studies, as there are few such 
studies of behavioral interventions implemented to improve oral health. The Guide to 
Community Preventive Services (17) typically conducts systematic reviews of the CE of an 
intervention after the effectiveness of the intervention has been established. Synthesizing CE 
ratios has been proven problematic because methods and reporting may vary across studies 
(18). Conducting the economic analysis while studying the effectiveness of the intervention 
may encourage the use of established protocols consistent with the recommendations of the 
Panel of Cost-Effectiveness in Health and Medicine (Panel) (19); in turn, such practices 
could improve the quality and uniformity of economic analyses (18,20). The findings may 
be used for dissemination and translation of effective interventions and may contribute to the 
understanding of factors influencing intervention effectiveness, CE, and components that 
may be altered to improve both.
This paper provides an overview of strategies for conducting economic evaluations of 
behavioral interventions for oral health promotion and disease prevention. Because it will 
not be possible to address every aspect of this topic or to provide detailed case studies, we 
reference books on economic analyses of health interventions (19,21–26). As this paper is 
structured to provide a framework for readers who may have little familiarity with economic 
analyses, the section Overview of economic terminology presents key concepts, including an 
overview of four types of economic analyses. The section Factors that influence the study 
design describes factors that influence the study design. Then we follow a project lifecycle 
and examine issues related to research design in the section Research design; a discussion of 
methods follows in the section Discussion. The section Research design includes 
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information on measures, data collection, and data analysis. To illustrate the described 
research methods, we refer to selected studies in the analysis section. These studies include 
behavioral interventions addressing oral health in clinical and nonclinical settings (27–31) 
and two studies, one of community water fluoridation programs (CWFP) (2) and another of 
school-based dental sealant programs (SBSP) (5), that do not focus on behavior change yet 
include strategies for assessing oral health costs and savings (see Table 1).
This overview aims to provide information both for those planning and conducting such 
studies and for experts in health planning and policy who would like an improved 
understanding of economic findings reported in published studies. The approaches described 
in this paper may also be used in studies of other oral health interventions and of health 
policy and reimbursement changes that influence the provision of oral health, as well as for 
program management, to clarify the impact of existing or planned resource allocations.
Overview of economic terminology
This section briefly describes four major types of economic analyses and different 
approaches to calculating costs. It then reviews questions that must be addressed prior to 
initiating the analysis: from whose perspective should the study be conducted?; how long 
will the study last and is the time frame sufficient to capture all outcomes associated with the 
intervention?; and what is the best strategy to collect data for the analysis?
Types of economic analyses
Economic analyses provide information to help decision-makers select among competing 
alternatives when resources are limited. The four types of economic analyses commonly 
used to assess health interventions include cost, CE, cost-utility, and cost-benefit (19,21–26). 
All collect information on costs (defined as the value of what is foregone when resources are 
used in a particular manner). All four types typically include measures of: a) intervention 
costs – the value of resources used to deliver the intervention; b) intervention savings – 
averted treatment and other costs attributable to the intervention; and c) net costs – the 
intervention costs netting out intervention savings.
The first type of economic analysis, a cost analysis, measures net costs. One aspect related to 
net costs is financial sustainability (the ability of the program to endure after the initial 
funding has stopped), which may be measured by including reimbursement and other 
sources of program revenue in estimates of net costs. Although cost analyses provide a good 
estimate of resource use, they are limited in their ability to assess efficiency because they do 
not provide a good measure of health outcomes gained from the intervention. The remaining 
three types of analyses compare costs to some measure of the intervention benefits.
A CE analysis (CEA) measures the net cost per health outcome achieved such as cases of 
disease prevented (19,22,24) and years of life saved (19,22,24). Oral health outcomes for 
CEA may include averted caries (12,28), tooth years gained (13), pocket probing depth 
reduction (13–15), and clinical attachment level gain (14,15). CEA provides good estimates 
of health outcome gained per dollar spent and is appropriate when comparing different 
interventions that influence the same health outcome. It is limited, however, in that the 
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health outcome measure may not include a measure of quality, and economic studies of 
interventions with different health outcomes cannot be compared to determine which 
intervention provides the best health investment.
A cost-utility analysis (CUA), which is a type of CEA, measures net costs per unit increase 
in a quality of life measure. The measure most commonly used for CUA is a quality-
adjusted life-year (QALY) (19,22,24). QALY measures health with the value”1”representing 
a year of perfect health and the value “0” representing death. Oral health-specific quality 
measures include a quality-adjusted tooth year (6,32) and oral health-related quality of life 
(OHrQOL) (33–35). Through the use of a common outcome in the denominator (e.g., 
QALY), CUA may be used to compare interventions that address different conditions (e.g., 
diabetes, heart disease, cancer).
A number of instruments have been developed to measure the morbidity associated with 
different conditions (i.e., QALY >0). All solicit information from individual study subjects 
on their relative valuation of living with the ill health associated with the condition vs. 
perfect health. There are little data on the relationship between oral disease and QALYs (36). 
OHrQOL involves a similar approach, using dimensions of oral health instead of general 
health to examine the impact of oral disease. OHrQOL can be decomposed into dimensions 
such as function, pain, appearance, and psychosocial impact and role functioning (33–35).
When comparing two or more interventions, researchers may conduct an incremental CEA 
or CUA analysis. An incremental CE ratio includes the difference in net costs between the 
two interventions in the numerator and the difference in outcomes in the denominator 
(21,24).
Cost-benefit analyses (CBA) compare the intervention costs to the monetary value of the 
achieved health benefits based on how much a person values the averted disease or how 
much he/she would be willing to pay to avoid the disease. Obtaining estimates of a person’s 
valuation of a health outcome [e.g., use of contingent valuation (37,38)] is typically resource 
intensive, and assigning a monetary value to health benefits such as a year of life is 
problematic (21). Because CBA is not used as frequently as the other types of economic 
analyses, we focus on cost, cost-effective, and CUAs in this paper.
Calculating costs
Two common approaches for assessing intervention costs and savings are to measure 
accounting costs and economic costs. Accounting costs, often referred to as financial costs 
or direct costs, are explicit monetary outlays for resources to provide or obtain services. 
They include medical costs (e.g., salaries and benefits for intervention personnel, medical 
supplies, household payments for health services) and nonmedical costs (e.g., travel costs). 
Such costs are generally recorded in an organization’s accounting system.
Economic costs include both accounting and indirect costs (i.e., implicit costs such as the 
market value of resources for which no money was spent).They include productivity losses 
and resources provided in-kind (e.g., office space and other capital resources). Examples of 
productivity losses include time spent by unpaid intervention personnel and the time costs 
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associated with traveling to, waiting for, and receiving dental services as well as time not 
spent conducting usual activities due to poor health. These are considered productivity 
losses, as they represent time away from regular work, household, and leisure activities.
Study perspective
Economic outcomes may be estimated from different perspectives (e.g., a health-care 
provider, a health system, a health payer, households, an employer, and society) (19,21–26). 
A health-care provider perspective may be that of a dental office, dental clinic, or group 
practice that includes dental and medical providers. In this paper, we employ the term health 
system to include private or public health-care providers that offer a range of medical, 
dental, pharmacy, outpatient, inpatient, and other services (e.g., Kaiser-Permanente, Indian 
Health Service). Health payers are public or private organizations that provide 
reimbursement or payment for health services. Examples of publicly funded programs 
include Medicare, Medicaid, and State Children’s Health Insurance Program (SCHIP). It is 
important to note that a health system may function as both a health-care provider and a 
health payer, and that a government entity (e.g., federal government) may be a health-care 
provider and health payer. Household costs may include direct and indirect costs associated 
with obtaining intervention services, using related health services, and poor health. The 
employer perspective may include that of a health payer with the addition of indirect costs 
associated with employees’ productivity losses due to poor health (39). Societal costs 
include all of the above costs – those of providers, payers, systems, households, and 
employers – and are generally estimated using economic rather than accounting costs.
To improve the conduct and reporting of CEA and CUA, the Panel (19) developed a list of 
recommendations that are analogous to the CONSORT statement (40) for medical 
researchers. The Panel recommended that CEA be conducted from the societal perspective 
so that findings may be used to determine the optimal allocation of scarce resources among 
competing alternatives. Also, this perspective provides a realistic estimate of the true cost of 
implementing an intervention.
Time frame and analytic horizon
Time frame refers to the duration of an intervention, whereas analytic horizon refers to the 
period over which all benefits and costs associated with an intervention are incurred. The 
analytic horizon is frequently longer than the time frame. For example, one study on the 
effectiveness of community water fluoridation found that exposure to water fluoridation in 
childhood (time frame) prevented tooth loss in adulthood (analytic horizon) (41).
Types of data collection
Economic studies of health interventions use different approaches to obtaining data. One 
approach, often referred to as micro-costing, tracks costs and savings associated with an 
intervention during the time frame of a study (19,24). For example, Hietasalo and colleagues 
(31) documented intervention costs, savings, and health benefits for each participant during 
the study time frame to estimate economic outcomes for an oral health behavioral health 
study.
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Another approach is to construct a decision cost model, based on findings from previously 
published studies and/or secondary data, to estimate intervention costs, effectiveness, and 
potential savings over an analytic horizon (19,24). This strategy is referred to as gross-
costing, as data used in the model are not derived from an intervention study. Decision cost 
models have been used to assess net savings associated with CWFP and SBSP (1,2,4,5).
A third, hybrid approach combines findings from an intervention study [e.g., randomized 
clinical trials (RCT) and comparative effectiveness research (CER) with data from other 
sources to develop a decision cost model to estimate short-term and long-term economic 
outcomes (42,43). The Panel recommends that all costs and health gains be included in a 
CEA. In situations where resources do not allow extending a CER or RCT time frame to 
capture all costs and benefits, modeling may be employed to estimate future costs and 
benefits.
Factors that influence the study design
Multiple factors are important to consider when designing economic studies of behavioral 
interventions. They include the service site, target population (e.g., an individual or family), 
data collection processes, phases of intervention implementation, and use of validated 
measures.
Intervention site of service and target population
The site of service for the intervention plays a key role, as intervention costs related to 
recruitment, participation, and retention may vary by service site. Oral health interventions 
for parents and caregivers of young children implemented at sites where such persons 
routinely come (e.g., Women, Infants, and Children clinics; Head Start centers; pediatric 
clinics) may have lower recruitment costs but may only reach those who access such 
services, and intervention frequency may be based on the schedule of services at the site. 
Programs implemented at other locations may have flexibility with regard to service 
frequency, yet may have higher recruitment and retention costs.
An intervention may be aimed at influencing behavior change at the family level (e.g., 
targeting caregivers of young children who may include parents, grandparents, other 
relatives, or guardians). Other interventions may focus services more specifically on 
individuals. Consequently, measures of costs and savings should be relevant to the defined 
target population.
Retrospective or prospective data collection
It is important to consider the study time horizon when assessing intervention costs and 
savings (e.g., whether data related to costs and savings will be collected prospectively or 
retrospectively). Prospective data collection throughout the intervention time frame allows 
for ongoing review of data and for modification of data collection methods to ensure 
accuracy and to address identified reporting issues.
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Phases of intervention implementation
Interventions may include different phases during which costs are incurred yet service 
provision varies. They include pre-implementation, start-up, steady-state, and wind-down 
phases. Costs associated with program development or adaptation may be incurred before 
intervention services are provided to participants. There may be a start-up or pilot phase 
when participant enrollment is relatively low and intervention cost per participant is higher 
than during the steady-state phase due to fixed salary costs of intervention personnel and 
personnel experience providing services. During a steady-state period, study enrollment may 
remain fairly constant and personnel are experienced at providing intervention services. 
Finally, the number of study participants may be lower at the end of the intervention time 
frame due to participant loss or earlier intervention completion for some participants. The 
cost per participant may be higher during this phase as well. It is important to consider 
intervention costs for each phase when determining the frequency of data collection.
Validated measures
If possible, cost measures, like other study measures, should have been validated in other 
studies and pilot tested in the current population. Use of validated measures for survey 
instruments may minimize biases associated with self-report data (e.g., recall bias) and 
provide guidance on appropriate time periods to include in such measures (e.g., past 6 
months or year). Pilot testing is especially important when the target population is culturally 
or economically different from that of previous studies (44).
Research design
Measures and data collection
In this section, we describe an array of cost measures, relevant for the economic analyses 
described above, and present methods and issues related to micro-costing such information. 
As with other study measures, it is important to ensure the fidelity of the data collection 
process while balancing accuracy and precision with data collection costs. It also is 
important to plan logistics related to data collection, tracking, quality checking, and storage.
Intervention costs—Table 2 provides a list of intervention costs (capital, noncapital one-
time fixed, and operating costs) that may be included in cost estimates. If prices are not 
available through microcosting, online references that provide cost data, such as those listed 
in Table 3, may be used. These sources may be used to estimate the current market price of 
materials and labor provided on an in-kind basis.
Capital costs include expenditures for items that may be used over several years, including 
facilities and equipment (e.g., Xerox machines, printers). Although the costs of these items 
may occur in one-time period, their benefits will span over their useful life. Thus, it is 
necessary to estimate the annual cost for each year of the equipment’s useful life by dividing 
the value of the equipment (i.e., purchase price) by the annuity factor that is based on the 
equipment’s useful life and the discount rate (i.e., 3 percent; see Table 3).
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Noncapital one-time fixed costs often include those associated with program development 
(e.g., costs associated with developing or adapting oral health education and promotion 
materials, developing or adapting training programs, developing logistics and processes). 
Expenditures for these costs need not be annuitized over their useful life span.
Operating costs are the ongoing costs required to provide intervention services that accrue 
over a budget period, usually calculated on an annual basis, such as personnel, program 
supplies, travel, reporting and documentation, and administrative costs. As with other costs, 
some vary by the volume of services provided and others do not.
When documenting costs associated with a study, it is important to distinguish research costs 
from those associated with actually providing an intervention. For example, some consultant 
costs may be associated with research methods, while others might be associated with the 
adaption of educational materials for use in the intervention. Similarly, personnel time may 
include time spent providing the intervention and time spent on research-related activities 
(e.g., writing a study protocol for institutional review board approval, attending a training to 
ensure measurement fidelity).
Personnel costs: For many behavioral interventions, personnel expenses constitute the 
majority of costs and will substantially influence intervention cost estimates. As such, 
detailed measurement is merited to ensure reliable and accurate data. This generally involves 
assessing personnel time for the intervention and assigning a dollar value to that time based 
on related costs (e.g., salaries, benefits). Two common strategies for assessing personnel 
time include use of time logs and time–motion studies (22,26). For both approaches, larger 
samples and collection of data throughout the intervention time frame increase the accuracy 
and precision of time estimates.
With either approach, personnel time spent on intervention activities should be accrued 
separately from time spent conducting research activities. Intervention activities may include 
travel to intervention sites, provision of oral health promotion and prevention services, 
scheduling intervention services, documentation and reporting, and management and 
supervision of intervention personnel. Research activities include trainings about research 
protocols, administration of study questionnaires that would not be utilized for an 
intervention in a non-research setting, and meetings about research methods. Some 
activities, such as study enrollment, may be considered both intervention and research 
activities. A uniform approach to assigning a proportion of time spent on such activities 
should be developed.
Figure 1 provides an example of a personnel time log for the pre-implementation phase of a 
study; Figure 2 provides a log for the intervention period. Time logs may be developed 
based on personnel job descriptions and responsibilities and should be pilot tested before 
being finalized to ensure that they accurately reflect activities. As with other intervention 
procedures, staff should be trained on their use. Logistical arrangements for their use may 
vary across implementation stages and by personnel types. For example, during pre-
implementation, the personnel may be asked to estimate time spent on various activities, 
based on a review of their calendars at the end of each month, while more detailed data may 
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be collected during the intervention time frame. Previous research indicates that personnel 
time spent completing logs at the end of a month may be no more than 5 minutes (45). The 
accuracy and costs of data collected retrospectively on a monthly basis, as compared to other 
time periods, should be evaluated based on personnel intervention activities. During the 
implementation phase, intervention personnel could be asked to prospectively complete a 
log at specific intervals (e.g., each work day during a representative week each quarter) to 
allow for data collection during the intervention start-up, steady-state, and wind-down 
phases.
When greater precision is needed, the best alternative to time logs usually will be a time–
motion study involving use of observers to record time data (22,26). This approach is 
effective for assessing time costs associated with an intervention activity that is added to a 
health-care provider’s routine array of services (e.g., the addition of oral health education 
and fluoride varnish application during a well-child visit for children less than 2 years of 
age). For either approach, the frequency of data collection (i.e., the sample size) may be 
determined based on information and estimates for the number of intervention staff, length 
of the intervention time frame, variety of intervention activities, variation in time spent on 
intervention activities, and reporting burden using a classical or Bayesian approach (25,26), 
and adjusted after an initial round of data collection.
Other personnel costs include those associated with recruitment, hiring, training, and staff 
turnover. While some may be included in organization overhead costs, direct costs such as 
training may be listed as a separate category. Indirect costs such as those associated with 
personnel experience are generally difficult to measure but may be represented in statistics 
concerning the number of services provided.
Other intervention costs: An extensive list of other intervention cost categories is provided 
in Table 2. Organizational overhead costs can vary substantially and thereby significantly 
influence intervention costs. Information on monetary outlays for these and other costs may 
be extracted from fiscal documents on a quarterly, semiannual, or annual basis.
Costs associated with utilization of other health services—Behavioral 
interventions implemented to improve oral health may alter utilization of other health 
services. Improvements in oral health may be associated with reductions in dental and 
medical service utilization for oral health problems, but intervention services may also 
increase utilization. For example, oral health screenings conducted as part of an intervention 
may lead to increased utilization of some dental services as persons are referred for follow-
up services based on screening results. It is also possible, however, that any type of service 
utilization may be associated with adverse effects and thereby increase utilization of health 
services. Information on changes in use of other health services may be used to assess 
intervention costs and savings.
Data on dental, medical, and pharmacy service utilization for oral health problems may be 
obtained from self-reports, clinical exams, and data extracted from medical records or health 
provider, system, or payer databases. The feasibility, benefits, and costs associated with the 
use of these data sources vary. For example, data costs associated with adding utilization 
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measures to existing study instruments are lower than they would be if an instrument were 
developed for this purpose. Two issues to consider when using self-report data are level of 
detail and recall bias. Although it is possible to include measures related to specific dental 
procedures such as tooth extractions and dental sealants, self-report data may lack detail 
related to the number and types of dental procedures provided in a dental clinic or office. 
Results of published studies indicate that the reliability of self-reports of dental service 
utilization varies by service type and frequency of data collection (46–48). It may be 
possible to examine potential reporting biases by comparing self-report data with data from 
an administrative database for a sample of intervention participants.
A study protocol may include use of a clinical oral health exam to assess oral health status. 
Exam data on the number and type of restorations may be used to assess costs associated 
with such treatments. However, these data do not include information on the site of service, 
types and costs of related procedures, and related household costs. It is possible to use a 
combination of self-report and clinical exam data to address weaknesses associated with the 
use of each data source on its own.
While dental and medical records include detailed information on procedures, health status, 
and dates of service, the costs of data extraction are significant. Electronic data stored in 
administrative databases for billing and other purposes include less detailed information, yet 
costs associated with data extraction are relatively lower. Some databases include 
information on the use of medical services (e.g., hospital emergency), as well as dental 
services, for oral health problems. Others, such as those of private dental insurers, generally 
do not.
Health service price estimates may be obtained from utilization data and published sources 
on provider service charges (e.g., American Dental Association report on dental fees) or 
reimbursement (e.g., Medicaid and SCHIP reimbursement rates; see Table 3). Although data 
on service charges and reimbursement are often used to estimate service costs, it is 
recognized that such measures may not reflect the true economic costs associated with the 
provided services.
Health provider, system, and payer revenue—Health providers and systems may be 
reimbursed for services by public or private insurers. To assess the impact of these and other 
revenue sources on an intervention’s financial sustainability, information on participant 
insurance status may be obtained via study participant self-report and from revenue data 
obtained from health provider, system, and payer databases.
Household costs—Households may incur direct and indirect costs due to study 
participation, health service utilization, and poor health. Direct costs are costs that families 
pay out of pocket for dental and medical services, travel to obtain services, oral health 
supplies, and other related items. Indirect costs are productivity losses, such as those 
associated with time spent traveling to provider offices, waiting for intervention services to 
be provided, and receiving dental services. They also include time away from day-to-day 
activities due to poor health or to caring for someone in poor health. The dollar value of 
these costs may be estimated from measures of time spent and related prices. The price or 
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value of a study participant’s time may be estimated from information on participant wages 
or from published estimates for the value of 1 hour of activity for men and women employed 
both inside and outside the home (22) (see Table 3).
Other costs—Assessing economic outcomes from the employer and societal perspectives 
often involves no additional data collection. Economic outcomes from an employer 
perspective may be derived from data on costs and savings associated with employee health 
and dental insurance and participant’s missed days of work (39). However, additional data 
may be collected to estimate human resource costs associated with hiring new employees 
should health status influence employment or other costs associated with employee benefits.
Data on the economic costs incurred by health providers, systems, and payers; households; 
and employers may be used to estimate economic outcomes from a societal perspective. 
However, there are many short-term and long-term costs associated with poor oral health 
that are intangible or difficult to assign a monetary value to (49). As noted above, OHrQOL 
may be used to assess these factors and a related change associated with improved oral 
health status (33–35). For example, the Pediatric Oral Health-related Quality of Life Parent 
Report on Child was found to be a valid and reliable measure for assessing parent-reported 
effects of oral conditions in preschool children on their physical, emotional, and role 
functioning (35). This OHrQOL measure may be useful in assessing benefits for behavioral 
interventions targeting caregivers of young children. Other OHrQOL measures, such as the 
Oral Health Impact Profile, may be used for interventions targeting adults (10,50–52).
Analysis
In this section, we refer to seven oral health studies to describe strategies for estimating 
economic outcomes from different perspectives. To locate relevant studies, we searched 
Pubmed for economic analyses on dental interventions published in English after 2004. Our 
search yielded 36 studies, of which 15 included economic analyses. Seven are included in 
Table 1. Of the remaining eight studies, three were on dental implants or treatment of dental 
fractures, one was on community water fluoridation, three were on delivering clinical dental 
care in settings other than the dental office, and one examined willingness to pay to prevent 
dental caries.
We begin with three studies that used micro-costing to estimate net costs associated with 
oral health education and preventive services targeting low-income, high-risk families 
(27,29,30,53). All three studies estimated net costs from the health-care provider 
perspective. Grant and colleagues (30) included salaries and dental supplies to estimate the 
costs of screening, parental counseling, and applying fluoride varnish in a dental clinic 
setting. Wennhall and colleagues (29) included facility, equipment, labor, and supply costs in 
their estimate of intervention costs; the cost and net cost per child were 310 and 30 euros, 
respectively. Kobayashi and colleagues (27) also included costs associated with training 
dental personnel, community outreach, and program marketing in their estimate of costs for 
a community-based program to increase preventive service utilization. Both Grant et al. (30) 
and Kobayashi et al. (27) reported net costs and an estimate of financial sustainability – net 
O’Connell and Griffin Page 11













costs including Medicaid reimbursement revenue, as both studies targeted households with 
children enrolled in Medicaid.
We next examine CWFP and SBSP economic analyses conducted from a societal 
perspective. Although they do not address behavioral health interventions, these studies 
illustrate strategies useful for behavioral health studies. O’Connell and colleagues (2) 
reported CWFP net savings based on a decision cost model that incorporated secondary data 
to estimate intervention costs for a 12-month period, caries reductions during the same 12-
month period, and intervention savings accrued over a lifetime due to caries reductions 
during the 12-month period. Through the use of decision analysis software, a Markov model 
was constructed to describe the probability of different types of initial and replacement 
restorations (e.g., single-surface amalgam, multisurface composite resin, crown) and 
extractions that may occur over a lifetime, and estimate related treatment costs which may 
be averted due to CWFP.
As the clinical effectiveness of dental sealants is well documented (54–56), a number of 
studies have examined sealant costs, net costs, and CE. In 2002, Griffin et al. reported net 
cost savings from the societal perspective using a decision cost model based on secondary 
data that provided a framework for other studies. More recently, Scherrer and colleagues (5) 
developed a cost model from data provided by seven-state SBSP and published findings to 
examine net costs from the health-care provider, state, and societal perspective. The model 
was used to examine the influence of program size (e.g., number of sealant stations, capital 
costs) and different combinations of personnel (i.e., dentists, dental hygienists, dental 
assistants) on program costs and savings. The authors reported that additional cost savings 
were associated with modifying Wisconsin’s dental practice act to allow dental hygienists to 
prescribe sealants without a dentist’s supervision.
Both studies (2,5) used software to construct cost models to conduct sensitivity analyses to 
examine the robustness of study findings to parameter estimates (i.e., the values of the 
measures) and to explore the impact of programmatic changes or unique community aspects 
on the economic outcomes. Decision analysis software was used for the CWFP study to 
develop a Markov model to incorporate probabilities of various health events occurring over 
a person’s lifetime and to conduct sensitivity analyses. The Panel recommends that, at a 
minimum, one-way sensitivity analyses be conducted where uncertainty or lack of 
agreement about some key parameters (e.g., program size, personnel costs) exists, to 
understand their influence on the economic outcomes (19). Multiway sensitivity analyses for 
important parameters are recommended (19). Parameter values may be varied within 
realistic ranges of the parameters’ distributions, such as those based on the mean and 
standard error of an estimate based on a normal distribution. Software may be used to 
estimate a confidence interval or credible range for a CE estimate. For example, a second-
order Monte Carlo probabilistic sensitivity analysis may examine the influence of variability 
in all cost parameters on the estimated economic outcomes. Such analyses make possible the 
calculation of a 95 percent credible range (the 2.5 percent to 97.5 percent) for each 
economic outcome. Similar to a confidence interval, a 95 percent credible range provides 
information about the variability of the estimated economic outcomes due to inherent 
uncertainty of some cost measures.
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Table 1 includes CEA findings for two RCTs of behavioral health interventions that included 
oral health education and preventive services. Both studies used micro-costing and assessed 
economic costs from a health-care provider perspective during the RCT time frame. 
Hietasalo et al. (31) reported the average incremental CE ratio as 34.07 euros per averted 
decayed, missing, and filled surface (DMFS) for a 3.4-year program serving children ages 
11–12 years. The incremental net costs over the intervention time frame were reported to be 
69.50 euros (95 percent credible range: 28.25–110.75). Annual incremental net costs during 
the later years of the intervention time frame were found to be lower as restorative costs for 
intervention children decreased. Using data for a 3-year intervention designed for mothers of 
infants living in low socioeconomic areas with high caries prevalence, Kowash et al. (28) 
estimated intervention costs and savings for a steady-state year and reported intervention 
costs per averted DMFS as 1.8 pounds. The intervention involved the provision of education 
focused on oral hygiene and nutrition through home-based visits of varying frequency over a 
3-year period.
As intervention costs and benefits may accrue over several years, economic analyses include 
adjustments for inflation and discounting (see Table 3). Published inflation rates for the 
economy as a whole and for certain sectors (e.g., medical and dental) may be used to convert 
dollars from varying time periods to those of 1 year, often referred to as the base year. Even 
in the absence of inflation, a dollar or a health benefit received today is worth more than that 
received tomorrow due to time preferences. For example, most persons would be willing to 
pay more for a positive health outcome today than waiting for a year. As a result, future 
costs and health outcomes must be discounted. The Panel recommends that CEA use a 
discount rate of 3 percent per year (19).
A number of other statistical issues arise when analyzing oral health and economic 
outcomes. One issue is missing data for participants lost to follow-up. Some investigators 
use conservative estimates concerning the intervention’s effectiveness for such participants 
(26). A second issue is the distribution of health and cost measures (25,26). The distribution 
of DMFS and treatment cost data is often highly skewed. For example, treatment costs can 
exhibit a large proportion of zero values for those who obtain no treatment and a limited 
number of very high values for those who obtain expensive types of treatment. 
Consequently, sample means may not fully account for such treatment costs, and statistical 
methods that address such distributions may be used. The third statistical issue concerns 
tooth loss. Oral health interventions for young children or older adults must account 
statistically for high rates of tooth loss associated with loss of primary teeth in the case of 
young children and permanent teeth among older adults. Finally, it is important not to 
double count costs, such as those for health services that may be incurred by households, 
health-care providers, and health payers. Because CUA includes a measure of time costs 
associated with poor health in the denominator (e.g., OHrQOL), such time costs should not 
be included in the numerator.
Discussion
This paper summarizes information and established protocols for conducting economic 
analyses of behavioral interventions implemented to improve oral health. Although the 
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literature on costs and CE of such interventions is fairly limited, we illustrated various 
methodologies (e.g., microcosting, gross-costing, decision cost models, sensitivity analysis) 
by describing methods and findings for seven oral health studies (2,5,27–31). Five of the 
studies examined behavioral interventions (27–31). While none included economic 
outcomes estimated from a societal perspective or potential savings for an analytic horizon 
longer than the intervention time frame (e.g., costs of maintaining a restoration overtime), 
the authors of two (28,31) discussed potential future savings that may accrue beyond the 
study time frame due to intervention effectiveness during that period.
In the description of research design considerations for conducting economic analyses, the 
recommendations of the Panel of Cost-Effectiveness in Health and Medicine’s were 
highlighted (19). These recommendations include use of a reference case analysis to 
enhance comparability across studies. The reference case should be based on a societal 
perspective, compare the health intervention of interest to at least one relevant alternative 
including doing nothing, include all pertinent costs, use a health-related quality-of-life 
measure to assess health benefits, have a time horizon that is long enough to capture all 
relevant future effects, adjust all costs for inflation, discount future costs and health benefits 
to their present value, and conduct a meaningful set of sensitivity analyses.
We recognize, given resource constraints, that it may not be feasible to implement these 
recommendations in all studies and comment on three considerations. First, conducting 
analyses from a societal perspective is important so that all relevant costs and benefits are 
accounted for. However, we acknowledge the importance of also having estimates based on 
a provider, payer, or government perspective as decisions concerning dissemination or 
translation of findings may be made by such entities. If resources preclude the measurement 
of some costs or benefits, their exclusion and influence on the findings should be addressed 
as a study limitation. Second, we know it may be difficult to assess the health impact in 
terms of health-related quality of life. At present, there is limited data linking oral conditions 
to QALY and no universally accepted OHrQOL measure. Adding a OHrQOL measure to a 
research protocol may also involve significant resources. As research advances, information 
linking oral health improvements to changes in QALY will facilitate comparisons among 
oral health interventions and those for other conditions, and contribute to decisions on the 
broad allocation of health resources. Finally, documentation of intervention costs could be 
improved by assessing all costs associated with each phase of development and by including 
all pertinent costs associated with personnel training, intervention outreach, participant 
scheduling, missed appointments, administration, and overhead. Use of standard protocols 
and detailed documentation of methods contribute to the quality and uniformity of economic 
analyses and allow for comparisons across interventions.
Researchers conducting economic studies of oral health behavioral interventions may learn 
from strategies employed in studies of other types of oral health interventions (10–13) as 
well as those of other conditions (e.g., diabetes, heart disease, cancer) (42,43,57–61) because 
economic studies, including estimates of long-term costs and benefits from a societal 
perspective, are more commonly conducted for interventions targeting such diseases. While 
we addressed several important methodological issues in this paper, we excluded others, 
such as measurement of net health benefits and use of a CE plane or acceptability curve to 
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graphically depict tradeoffs between intervention costs and health benefits. Detailed 
information on these and other important issues may be found in books dedicated to this 
topic (19,21–26).
Costs and CE findings derived from RCT or CER studies inform decisions about the 
dissemination and translation of interventions found to be clinically effective, culturally 
acceptable, and organizationally sustainable. At the same time, information on costs and 
potential savings of interventions with undocumented health benefits may contribute to the 
assessment of intervention components that may be altered to improve clinical effectiveness. 
Knowledge of resources needed to implement behavioral health interventions and their 
influence on health providers, systems, payers, employers, and society may increase the 
provision of effective interventions which may not only improve oral health status but also 
reduce oral health disparities.
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Example of an intervention time log for personnel during the preimplementation period.
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Example of an intervention time log for personnel during the intervention time frame.
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Table 2
Examples of Intervention Non-Personnel Cost Categories




Large electronic (e.g., copiers, printers)
Small electronic (e.g., cameras, cell phones, PDAs)















Other types of personnel




Information technology and computer supplies




Clinical intervention Medical supplies
Laboratory tests
Pharmaceuticals
Nonclinical intervention Printed materials














Overhead‡ Facility and administrative
Human resource
*
Facility costs could be capitol or operating costs. In this table they are listed as operating costs.
†
Such costs may be one-time fixed costs or costs that are incurred throughout an intervention time frame.
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‡
Overhead costs may include those associated with office space, utilities, information systems, human resources, and other activities necessary for 
program operations, and their costs may not be included as a line item in the intervention budget. Human resource costs may or may not include 
costs associated with hiring intervention personnel and related payroll and benefit services.
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Table 3
References for Price Estimates for Intervention Personnel, Equipment, Productivity Losses, and Other Costs
Category Type of cost Description Source
Health
services
Dental services The American Dental Association (ADA) 2009 Survey 
of Dental Fees
includes national summary statistics of fees charged by 
dentists.
http://www.ada.org/1619.aspx*
Medicaid reimbursement: The ADA Medicaid 
Compendium Update









Medical services: Use the US Department of Labor, 
Bureau of Labor
Statistics website and type in the series identification 
number. Use




Dental services Use the US Department of Labor, 
Bureau of Labor
Statistics website and type in the series identification 
number. Use




Wages foregone Annual and hourly wages for all US states http://www.bls.gov/oes/current/oessrcst.htm
Benefits foregone
Value of a lost day
Estimates of benefits are only available at the federal 
level.
Estimates for time of persons who work and who do 
not work
http://www.bls.gov/data/#wages
Table I.1(a)-(c) in Prevention
Effectiveness, A Guide to Decision
Analysis and Economic Evaluation
(19)*




Annuity factor To estimate the annual cost of capital equipment, 
authors recommend
using annuity factors based on a 3% discount rate, per
recommendation of the US Panel on Cost-effectiveness 
in Health and
Medicine (16), and equipment useful lives ranging 
from 1 to 25 years.
Table 2 of Appendix C in SEALS Users
Manual available at
http://www.chawisconsin.org/sas.htm
Note that nearly all of the listed references may be accessed free of charge. Those marked with an
*
require payment to purchase.
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